AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2139.952.1 (+0.1 %)
PREV CLOSE ( ) 2137.85
OPEN PRICE ( ) 2159.95
BID PRICE (QTY) 2134.30 (4)
OFFER PRICE (QTY) 2139.20 (4)
VOLUME 1359
TODAY'S LOW / HIGH ( )2124.50 2159.95
52 WK LOW / HIGH ( )1240.55 2355.05
NSE2135.35-4.6 (-0.21 %)
PREV CLOSE( ) 2139.95
OPEN PRICE ( ) 2144.00
BID PRICE (QTY) 2135.30 (6)
OFFER PRICE (QTY) 2138.30 (4)
VOLUME 42213
TODAY'S LOW / HIGH( ) 2122.65 2157.20
52 WK LOW / HIGH ( )1246.75 2353.95
Exchange
Year Open Price () High Price () Low Price () Close Price () Volume (000's) Value (lakhs)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.